Yahoo Finance 3 Marijuana Stocks That Have Moved Up Big In The Last Week
CORAL GABLES, FL / ACCESSWIRE / November 6, 2018 / Marijuana stocks have seen a surge of attention this year. Canaccord analyst Bobby Burleson said in a research note, "We believe his year's midterms will reinforce the notion that cannabis in the U.S. has (passed) the tipping point on its way to eventual full legal status."
Early in the year, Wall Street and investors saw a slew of deal-making, uplisting, and production capacity expansion that marijuana stocks demonstrated. Grand View Research states that the global legal marijuana market size was valued at $9.3 billion in 2016 and is expected to exhibit a CAGR of 34.6% during the forecast period. The market is expected to witness significant growth owing to legalization in several countries and high demand for both medical and recreational purposes.
As more investors eye the growing cannabis industry, three marijuana stocks to watch this week include Integrated Cannabis Company (ICNAF) (ICAN.CN), Cronos Group (CRON) (TSX:CRON.TO) and Emerald Health Therapeutics (EMHTF) (EMH)
Integrated Cannabis Company (ICNAF) (ICAN) has seen its shares climb by more than 50% over the last 2 months. On September 5, the opening price was $0.46 and Tuesday saw shares of Integrated Cannabis Company (ICNAF) (ICAN) rallying to highs of $0.70.
Integrated Cannabis Company (ICNAF) (ICAN) currently has a product portfolio of CBD and THC oral sprays and has also begun expanding its offering for new products. In a recent announcement, Integrated Cannabis Company (ICNAF) (ICAN) announced an agreement to license Cannabidiol (CBD) formulated gummies.
Integrated Cannabis plans to begin distributing CBD-based gummies through its contract manufacturer, Titration Technologies, in Phoenix, Arizona.
Integrated Cannabis Company (ICNAF) (ICAN) previously announced the completion of a market-ready Tetrahydrocannabinol-infused spray product and the required licensure for manufacturing of the product in Colorado. The THC product employs the same nanotechnology used to enhance the CBD-infused X-SPRAYS™, resulting in higher bioavailability and faster uptake versus capsules or powder
For More Information On Integrated Cannabis Company (ICNAF) (ICAN), Click Here
Cronos Group (CRON) (CRON.TO) also saw shares jump on Tuesday. At the beginning half of last week, shares of Cronos hit lows of $6.50 and today the company's stock reached early highs of $9.10 representing a 40% move over the last week.
Cronos Group (CRON)(CRON.TO) will announce its financial results and hold its Third Quarter 2018 Earnings Conference Call on Tuesday, November 13, 2018 at 8:30 a.m. EDT. Senior management will be available for questions from the investment community after prepared remarks.
In response to the recent legalization efforts in Canada, Cronos CEO Mike Gorenstein, stated, "At Cronos, we take pride in leading the industry forward responsibly and are motivated to create meaningful products that excite our consumers and bring happiness and an improved quality of life. The growth potential in the cannabis industry is vast and extends well beyond the flower. With our differentiated brands, global footprint, growing production capacity and commitment to cannabinoid innovation, Cronos is well positioned to realize this opportunity."
For More Information On Cronos Group, Click Here
Emerald Health Therapeutics (EMHTF) (EMH) announced that it has filed 17 provisional US patent applications covering Emerald's unique Defined Dose™ cannabis dosage forms and formulations. Based on proprietary Emerald research, these patent applications are contributing to Emerald's intellectual property portfolio and its intent to develop distinctive cannabis products for medical-use and improved adult-use.
The products provide more precise and consistent delivery, dosage, and formulations. Defined Dose™ cannabis products will, when made available to the public, provide consumers with products currently not available.
"We expect significant potential cannabis market growth by offering adult users and medical consumers consistent product characteristics, dosing regimens, and alternative methods of consumption, with safety enhanced through GMP-compliant production and enhanced product utility achieved through knowledge of science. Emerald's filing of these patent applications is an important step," said Chris Wagner, CEO of Emerald.
Shares of the company's stock have jumped by nearly 60% within the last week.
For More Information On Emerald Health, Click Here
About marijuanastocks.com
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 2 months beginning September 4, 2018, and ending March 9, 2019. This payment has been increased to $75,000 per month for the period of November 4 2018 and ending March 9, 2019. We own ZERO shares of Integrated Cannabis Company. We may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company. MarijuanaStocks.com, which is owned by MAPH Enterprises LLC., a Florida Corporation has been previously compensated $100,000 by a non-affiliate 3rd party for a 1 year period beginning August 1, 2017 and ending August 1, 2018 to publicly disseminate information about CNRP Mining, Inc. (CND.CN) (CRPGF) that is now Integrated Cannabis Company. Please click here for full disclaimer
Contact Information:
SOURCE: MarijuanaStocks.com
